Press release
Infectious Diseases Therapeutics Market to Rear Excessive Growth to 2020
Globally, major burden on public health is posed by infectious diseases such as HIV, malaria, tuberculosis, hepatitis A, hepatitis C, hepatitis C and influenza. Infectious diseases are the major cause of death in the world. According to World Health Organization (WHO), globally 16% of deaths are resulted due to infectious diseases. Various pathogen microorganisms, such as parasites, virus, bacteria and fungi, cause infectious diseases. Poor sanitation and inadequate personal hygiene causes various infectious diseases. These diseases are transmitted through direct or indirect contact. Anti-infective drugs are used to prevent or destroy the growth of pathogens. Antibacterial, antiviral, antifungal and antiparacitic drugs are some of the anti- infective drugs used for the treatment of infectious diseases.A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/3380
North America dominates the global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and rise in aging population. Asia followed by the Europe are expected to show high growth rates in the next five years in the global infectious diseases therapeutics market. China and India are expected to be the fastest growing infectious diseases therapeutics markets in Asia-Pacific region. Some of the key driving forces for infectious diseases therapeutics market in emerging countries are large pool of patients and rising government funding.
In recent times there is increased use of infectious diseases therapeutics due to increasing incidence of infectious diseases. Increase use of direct acting anti-viral, increase in geriatric population and increasing healthcare expenditure are some of the key factors driving the growth for the global infectious diseases therapeutics market. In addition, increasing healthcare awareness is also fuelling the growth of the global infectious diseases therapeutics market. However, generic erosion is the major factors restraining the growth for the global infectious diseases therapeutics market.
Patent expiration of infectious disease drugs could lead a challenge for the global infectious diseases therapeutics market. Some of the trends for the global infectious diseases therapeutics market are emergence of interferon free regimes and increasing awareness programs. Some of the major companies operating in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/3380
Key points covered in the report
Report segments the market on the basis of types, application, products, technology, etc (as applicable)
The report covers geographic segmentation
North America
Europe
Asia
RoW
The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Diseases Therapeutics Market to Rear Excessive Growth to 2020 here
News-ID: 723625 • Views: …
More Releases from Persistence Market Research
Blood Collection Tubes Market Size, Growth, Share & Trends 2025-2032 | Global In …
The blood collection tubes market plays a pivotal role in modern healthcare by enabling safe, efficient, and accurate collection, storage, and transportation of blood samples. Extensively used in diagnostic laboratories, hospitals, and research centers, these tubes are critical for hematology, biochemistry, immunology, and molecular testing. They help maintain sample integrity, minimize contamination risks, and streamline laboratory workflows, making them indispensable in clinical diagnostics.
Request a Sample:
https://www.persistencemarketresearch.com/samples/35126
Market Overview
According to a recent study…
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from…
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising…
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a…
More Releases for Infectious
Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market.
Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210
The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays…
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63
The U.S. FDA (United States Food and Drug Administration) is…
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which…
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of…
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques.
The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased…
